Total Payments
$6,290
2024 Payments
$2,433
Companies
29
Transactions
258
Medicare Patients
2,388
Medicare Billing
$168,181
Payment Breakdown by Category
Food & Beverage$6,290 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,290 | 258 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,986 | 84 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $583.16 | 29 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $513.90 | 25 | $0 (2024) |
| Janssen Biotech, Inc. | $445.75 | 17 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $327.13 | 14 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $277.82 | 5 | $0 (2023) |
| QOL Medical, LLC | $276.19 | 13 | $0 (2024) |
| Ardelyx, Inc. | $266.11 | 8 | $0 (2024) |
| Gilead Sciences, Inc. | $260.16 | 12 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $180.14 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,433 | 100 | ABBVIE INC. ($674.77) |
| 2023 | $2,162 | 87 | ABBVIE INC. ($407.80) |
| 2022 | $615.25 | 26 | ABBVIE INC. ($376.67) |
| 2021 | $1,080 | 45 | AbbVie Inc. ($526.95) |
All Payment Transactions
258 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: Gastroenterology | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $26.92 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.59 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/02/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: Gastroenterology | ||||||
| 12/02/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 11/26/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $10.35 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $33.11 | General |
| Category: VIROLOGY | ||||||
| 11/15/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/13/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.88 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: Immunology | ||||||
| 10/30/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $91.76 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/29/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/25/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: LIVER DISEASE | ||||||
| 10/22/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.42 | General |
| Category: Immunology | ||||||
| 10/15/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/14/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $33.55 | General |
| Category: LIVER DISEASE | ||||||
| 10/11/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: Rare Disease | ||||||
| 10/10/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $28.33 | General |
| Category: LIVER DISEASE | ||||||
| 10/09/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 10/08/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $121.80 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 729 | 805 | $206,558 | $58,681 |
| 2022 | 6 | 540 | 556 | $115,659 | $34,119 |
| 2021 | 6 | 1,009 | 1,079 | $192,321 | $69,468 |
| 2020 | 3 | 110 | 113 | $17,203 | $5,914 |
Total Patients
2,388
Total Services
2,553
Medicare Billing
$168,181
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 311 | 385 | $99,819 | $30,306 | 30.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 156 | 156 | $52,788 | $14,233 | 27.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 143 | 143 | $32,630 | $8,239 | 25.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 96 | 98 | $17,954 | $5,333 | 29.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 23 | 23 | $3,367 | $570.17 | 16.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 132 | 143 | $34,740 | $11,045 | 31.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 84 | 84 | $28,055 | $8,242 | 29.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 124 | 129 | $19,866 | $6,565 | 33.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 91 | 91 | $19,843 | $4,432 | 22.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 64 | 64 | $6,408 | $2,055 | 32.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 45 | 45 | $6,746 | $1,780 | 26.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 264 | 321 | $44,699 | $17,359 | 38.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 253 | 253 | $51,447 | $16,058 | 31.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 162 | 172 | $34,518 | $14,626 | 42.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 137 | 137 | $40,955 | $14,159 | 34.6% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 154 | 157 | $15,072 | $5,767 | 38.3% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 39 | 39 | $5,630 | $1,498 | 26.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 52 | 55 | $7,645 | $2,866 | 37.5% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 38 | 38 | $7,638 | $2,434 | 31.9% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 20 | 20 | $1,920 | $612.94 | 31.9% |
About Sarah Proffit, NP-C
Sarah Proffit, NP-C is a Registered Nurse healthcare provider based in Salisbury, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/18/2020. The National Provider Identifier (NPI) number assigned to this provider is 1104459270.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sarah Proffit, NP-C has received a total of $6,290 in payments from pharmaceutical and medical device companies, with $2,433 received in 2024. These payments were reported across 258 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($6,290).
As a Medicare-enrolled provider, Proffit has provided services to 2,388 Medicare beneficiaries, totaling 2,553 services with total Medicare billing of $168,181. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Registered Nurse
- Other Specialties Family
- Location Salisbury, MD
- Active Since 02/18/2020
- Last Updated 09/08/2022
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1104459270
Products in Payments
- LINZESS (Drug) $673.72
- XIFAXAN (Drug) $509.99
- MAVYRET (Drug) $444.60
- RINVOQ (Biological) $337.77
- OCALIVA (Drug) $327.13
- ENTYVIO (Biological) $315.54
- ZEPOSIA (Drug) $296.16
- CREON (Drug) $285.41
- IBSRELA (Drug) $266.11
- REBYOTA (Biological) $265.68
- TREMFYA (Drug) $261.58
- Sucraid (Drug) $224.09
- STELARA (Biological) $184.17
- VOQUEZNA (Drug) $180.14
- VIBERZI (Drug) $136.63
- MOTEGRITY (Drug) $111.99
- SUTAB (Drug) $98.61
- AMJEVITA (Biological) $92.80
- DUPIXENT (Biological) $87.89
- RESMETIROM (Drug) $86.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Salisbury
Ms. Teresa Gilliland, Fnp-C, FNP-C
Registered Nurse — Payments: $4,206
Registered Nurse $4,206
Lavon Landis, Pmhnp, PMHNP
Registered Nurse — Payments: $3,643
Registered Nurse $3,643
Melinda Webb, Arnp, ARNP
Registered Nurse — Payments: $1,713
Registered Nurse $1,713
Mrs. Allison Kidney
Registered Nurse — Payments: $1,680
Registered Nurse $1,680
Mrs. Meriam Okani, Crnp, Fnp-C, CRNP, FNP-C
Registered Nurse — Payments: $1,346
Registered Nurse $1,346
Michelle Thomason, Pnp, PNP
Registered Nurse — Payments: $845.70
Registered Nurse $845.70